NOVEL INHIBITORS OF FARNESYL TRANSFERASE, PROCESS OF THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INHIBITORS

PCT No. PCT/FR96/00198 Sec. 371 Date Aug. 1, 1997 Sec. 102(e) Date Aug. 1, 1997 PCT Filed Feb. 7, 1996 PCT Pub. No. WO96/24611 PCT Pub. Date Aug. 15, 1996Novel farnesyl transferase inhibitors of general formula (I) (I) preparation thereof and pharmaceutical compositions containing same. In general f...

Full description

Saved in:
Bibliographic Details
Main Author CLERC FRANCOIS-FREDERIC
Format Patent
LanguageEnglish
Published 12.11.1997
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PCT No. PCT/FR96/00198 Sec. 371 Date Aug. 1, 1997 Sec. 102(e) Date Aug. 1, 1997 PCT Filed Feb. 7, 1996 PCT Pub. No. WO96/24611 PCT Pub. Date Aug. 15, 1996Novel farnesyl transferase inhibitors of general formula (I) (I) preparation thereof and pharmaceutical compositions containing same. In general formula (I), R1 is Y-S-A1- (where Y is a hydrogen atom, an amino acid residue, a fatty acid residue, an alkyl or alkoxycarbonyl radical, or a radical R4-S-, where R4 is a C1-6 alkyl radical optionally substituted by a phenyl radical, or a radical of general formula (II), (II) wherein A1, X1, Y1, R'2, R'2, X2, Y2, R3, R'3 and R are as defined below, and A1 is a C1-4 alkylene radical optionally alpha -substituted in the >C(X1) (Y1) grouping by an amino, alkylamino, alkanoylamino or alkoxycarbonylamino radical); X1 and Y1 are each a hydrogen atom or, taken together with the carbon atom to which they are attached, a >C=O grouping; R2 is a straight or branched C1-4 alkyl radical optionally substituted by a cyclohexyl radical; R'2 is hydrogen or alkyl; X2 and Y2 are each a hydrogen atom or, taken together with the carbon atom to which they are attached, a >C=O grouping; R3 is a C1-4 alkyl radical optionally substituted by hydroxy, alkoxy, mercapto, alkylthio, alkylsulphinyl or alkylsulphonyl, with the proviso that, when R3 is an alkyl radical substituted by a hyroxy, alkoxy, mercapto, alkylthio, alkylsulphinyl or alkylsulphonyl, with the proviso that, when R3 is an alkyl radical substituted by a hydroxy radical, R3 may form a lactone with the alpha -carboxy radical; R'3 is hydrogen or alkyl; X is an oxygen or sulphur atom; and R is a hydrogen atom or an optionally substituted alkyl radical or an optionally substituted phenyl radical. These novel products have anticancer properties.
AbstractList PCT No. PCT/FR96/00198 Sec. 371 Date Aug. 1, 1997 Sec. 102(e) Date Aug. 1, 1997 PCT Filed Feb. 7, 1996 PCT Pub. No. WO96/24611 PCT Pub. Date Aug. 15, 1996Novel farnesyl transferase inhibitors of general formula (I) (I) preparation thereof and pharmaceutical compositions containing same. In general formula (I), R1 is Y-S-A1- (where Y is a hydrogen atom, an amino acid residue, a fatty acid residue, an alkyl or alkoxycarbonyl radical, or a radical R4-S-, where R4 is a C1-6 alkyl radical optionally substituted by a phenyl radical, or a radical of general formula (II), (II) wherein A1, X1, Y1, R'2, R'2, X2, Y2, R3, R'3 and R are as defined below, and A1 is a C1-4 alkylene radical optionally alpha -substituted in the >C(X1) (Y1) grouping by an amino, alkylamino, alkanoylamino or alkoxycarbonylamino radical); X1 and Y1 are each a hydrogen atom or, taken together with the carbon atom to which they are attached, a >C=O grouping; R2 is a straight or branched C1-4 alkyl radical optionally substituted by a cyclohexyl radical; R'2 is hydrogen or alkyl; X2 and Y2 are each a hydrogen atom or, taken together with the carbon atom to which they are attached, a >C=O grouping; R3 is a C1-4 alkyl radical optionally substituted by hydroxy, alkoxy, mercapto, alkylthio, alkylsulphinyl or alkylsulphonyl, with the proviso that, when R3 is an alkyl radical substituted by a hyroxy, alkoxy, mercapto, alkylthio, alkylsulphinyl or alkylsulphonyl, with the proviso that, when R3 is an alkyl radical substituted by a hydroxy radical, R3 may form a lactone with the alpha -carboxy radical; R'3 is hydrogen or alkyl; X is an oxygen or sulphur atom; and R is a hydrogen atom or an optionally substituted alkyl radical or an optionally substituted phenyl radical. These novel products have anticancer properties.
Author CLERC FRANCOIS-FREDERIC
Author_xml – fullname: CLERC FRANCOIS-FREDERIC
BookMark eNqFjT0KwkAQhVNo4d8ZnANoo4KmHNeJO5DMht2NoE0IslaSBOIFvLlRLOysHu99H7xxNKibOoyip5gTpcCiec_eWAcmgQStkDun4C2KS8iiowXk1ihyH8FrYtsPlKNFz0YA5QC5RpuhosKzwhSUyXLj-I1dX8QjC8sRXKH0z-E0Gt6qexdm35xE84S80svQNmXo2uoa6vAo1WW1iXfxFtfr_8YLl18-Og
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID CZ249897A3
GroupedDBID EVB
ID FETCH-epo_espacenet_CZ249897A33
IEDL.DBID EVB
IngestDate Fri Jul 19 15:08:49 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CZ249897A33
Notes Application Number: CZ19970002498
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19971112&DB=EPODOC&CC=CZ&NR=249897A3
ParticipantIDs epo_espacenet_CZ249897A3
PublicationCentury 1900
PublicationDate 19971112
PublicationDateYYYYMMDD 1997-11-12
PublicationDate_xml – month: 11
  year: 1997
  text: 19971112
  day: 12
PublicationDecade 1990
PublicationYear 1997
RelatedCompanies RHONE-POULENC RORER S. A
RelatedCompanies_xml – name: RHONE-POULENC RORER S. A
Score 2.475018
Snippet PCT No. PCT/FR96/00198 Sec. 371 Date Aug. 1, 1997 Sec. 102(e) Date Aug. 1, 1997 PCT Filed Feb. 7, 1996 PCT Pub. No. WO96/24611 PCT Pub. Date Aug. 15, 1996Novel...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NOVEL INHIBITORS OF FARNESYL TRANSFERASE, PROCESS OF THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19971112&DB=EPODOC&locale=&CC=CZ&NR=249897A3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwELZKQcAGBVTeHlAmKqiTknSIkOs4JKhxIietoEuVp2BJKxrEzD_HDi106eaXzvJJn3323XcG4EbAP4t7hXSrZ4W4oHTjjhGnSSdBudGV9q2uS3Kyxx6ckfb80ntpgLcVF6bOE_pVJ0cUiEoF3qt6v57_P2JZdWzl4i55F02zRzsyLSVb0sV0AV2kWAOTBr7lE4UQk0wUxk1xyzD6Ola3wLYwonWJBToeSE7KfP1AsQ_ATiBkldUhaORlC-yR1b9rLbDrLd3dorhE3uIIfDN_TIfQZY47cCOfh9C3oY05o-HrEEYcs9CmHIf0FgbcJ0KtckDkUJeLBhrg38coiJkFAwdzDxM6imQyBEh8L_BDt-YTiwqLsMtc9gTDEXHWJjwG1zaNiNMRa5n-qW1KJqtFqyegWc7KvA1gco9STS1SpKNEQ3li9OMi66ZpH6WqoRnaKWhvknK2uesc7NdpXWV4HLoAzerjM78Uh3WVXNV6_gEjtpFJ
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFG8QjXhT1OAnPZidJEo33DgspnSdm27dsg2CXMg-oxcgMuPZ_9x2gnLh1q-8ti_59ev19x4ANxz-WdwrhFk9K_gFpRt3tDhNOgnKta4436qqICe77MEaKs_j3rgG3tZcmMpP6FflHJEjKuV4L6v1evH_iGVUfyuXd8k7L5o_mpFuSNmKLqZy6CLJGOjU9wyPSIToZCKxQOe3DK2vYnkH7PIBaCLWAR0NBCdlsbmhmIdgz-eyZuURqOWzJmiQddy1Jth3V-Zunlwhb3kMvpk3og60mWUP7MgLQuiZ0MQBo-GrA6MAs9CkAQ7pLfQDj3C1igaRRe2AF1Af_z5GQcwM6Fs4cDGhw0g4Q4DEc30vtCs-Mc-wCNvMZk8wHBJro8MT0DZpRKwOn8v0T21TMllPWj4F9dl8lrcATO5RqshFilSUKChPtH5cZN007aNU1hRNOQOtbVLOt1e1QcOKXGfq2OzlAhxULl7FVzl0Cerlx2d-xTfuMrmudP4DHJ2UOQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+INHIBITORS+OF+FARNESYL+TRANSFERASE%2C+PROCESS+OF+THEIR+PREPARATION+AND+PHARMACEUTICAL+COMPOSITIONS+CONTAINING+SUCH+INHIBITORS&rft.inventor=CLERC+FRANCOIS-FREDERIC&rft.date=1997-11-12&rft.externalDBID=A3&rft.externalDocID=CZ249897A3